Page 127 - MemoriaEHD-Eng

www.ciberehd.org

• r-e a, M-g Ja, a-M a, s-r Ma, M--r p,
uizxtreMerauñozáMezBriLoLiNaaLMeróNuizuñozDeueDaMost relevant
pavóN-CastiLLero eJ. Variation of transaminases, HCV-RNA levels and Th1/Th2 cyto-
scientific kine production during the post-partum period in pregnant women with chronic

articles
hepatitis C.PLoS One. 2013;8(10):e75613.

• López-roDríguez r, herNáNDez-BartoLoMé á, BorQue MJ, roDríguez-Muñoz y, MartíN-

víLChez s, trapero-MarugáN M. Polymorphisms in histone deacetylases improve the
predictive value of IL-28B for chronic hepatitis C therapy.Genes Immun. 2013 Jul-

Aug;14(5):317-24.

• viota JL, Carazo a, MuNoz-gaMez Ja, ruDzKa K, góMez-sotoMayor r, ruiz-extreMera a.
Functionalized magnetic nanoparticles as vehicles for the delivery of the antitumor

drug gemcitabine to tumor cells. Physicochemical in vitro evaluation.Mater Sci Eng
C Mater Biol Appl. 2013 Apr 1;33(3):1183-92.

• p-C eJ, M--r p, L-s r, g a, Q r, M-g Ja.
avóNastiLLerouñozDeueDaópezeguraiLauiLesuñozáMez
Importance of IL-10 and IL-6 during chronic hepatitis C genotype-1 treatment and ñ

their relation with IL28B.Cytokine. 2013 Feb;61(2):595-601.

• Muoz-gáMez Ja, saLMeróN J. Prevalence of hepatitis B and C in Spain - further data
are needed.Rev Esp Enferm Dig. 2013 May;105(5):245-248.

During the year 2013 has been granted us two projects, one national and other
Highlights
Á
autonomic:

• Title: Circadian regulation of cancer stem cells in Colorectal Cancer markers. Exp:
PI-0677 - 2013. Principal investigator: Josefa Leon Lopez. Funding: Consejería
í
de Salud, Igualdad y Polticas Sociales, Junta de Andalucía. Duration: 3 years.
í
• Title: Study of tracking (TV) transmission of the virus of hepatitis C (HCV) and úí

hepatitis B (HBV): analysis of factors involved. Exp: PI13-01925. Funding:
Instituto de Salud Carlos III (FIS). Duration: 3 years. PRINCIPAL investigator:

Angeles Ruiz Extremera.

The number of active competitive projects carried out this year is a total of 4, in-

cluding an Intrasalud project, one of the Excellence of the University of Granada,
a FIS and one of the Consejera de Salud de Andalucía. The results have given rise

to a large number of communications: 12 in national congresses and 9 in interna-

tional congresses. Two national communications received the award for the best
poster of liver (LXXII annual Congress of the EDPS) communication and the best

clinical oral communication (XXXVIII annual Congress of the AEEH).

On the other hand, at the end of 2013 was presented a patent which has been
accepted at the beginning of the year 2014 (P-06781), whose name is “Polimorfis-

mos para predecir o pronosticar la respuesta al tratamiento antiviral”. Our Group

collaborated with other members of the CIBER (Dr. Manuel Romero Gomez, Dr. 13
Manuel de la Mata and Dr. Ral Andrade) and the Hospital de la Princesa of Ma- é20
T
drid, Dr. Ricardo Moreno Otero and Clinic of Barcelona, Dr. Jos Luis Martín Ruiz, OR
P
(Study CROMO).
RE
In addition the Dr. ngeles Ruz Extremera has published with the University of L
A
Granada publishing the book entitled: Pediatrics in Sciences of health, ISBN: NU
N
9788433854810.
A
D /
H
E
ER
IB
C

127